Published on in CHOP News
Using a model developed at CHOP, researchers find high cost of treatment most likely to prevent premature death in patients with agammaglobulinemia undermines its benefits.
Published on in CHOP News
Since March 2020, CHOP researchers have played a vital role in combatting the COVID-19 pandemic. Read highlights of their game-changing work.
Published on in CHOP News
CHOP researchers discovered a new condition, which they named PU.MA, and treated a patient with a bone marrow donation from the patient’s older brother.
Published on in CHOP News
Using deep immune profiling, CHOP researchers have found children with MIS-C are extremely immune activated, more like adults with severe COVID-19.
Published on in CHOP News
CHOP researchers found the elevated biomarker in all children who tested positive for SARS-CoV-2, whether they were symptomatic for COVID-19 or not.
Published on in CHOP News
CHOP researchers show convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19.
Published on in CHOP News
Breaking Through with Madeline Bell’s “Where We Are Now” series highlights CHOP doctors and researchers who are working to bring an end to the COVID-19 pandemic.
Published on in Children's Doctor
Latest news including COVID-19 models, care and research.
Published on in CHOP News
CHOP researchers have identified lab profiles that differentiate MIS-C from severe COVID-19 in children.
Published on in Children's View
Understanding the biology of both COVID-19 illness and MIS-C will enable scientists to develop much more specific diagnostic tests and help clinicians identify children who are at risk.